El Camino Hospital is a non-profit hospital with 420 beds based on a 41-acre campus in Mountain View, California. There is a second, smaller hospital campus, El Camino Hospital, Los Gatos, in Los Gatos, with additional satellite clinics in the West Valley/Lower Peninsula area of Silicon Valley.

During the past decade, El Camino Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 67 clinical trials were completed, i.e. on average, 335% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 26 clinical trials were completed. i.e. 325% of trials that started reached the finish line.

Out of the total clinical trials conducted in "El Camino Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 38 trials, followed by "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored, "Abbott Medical Devices" with 6 trials sponsored and "Boston Scientific Corporation" with 6 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "El Camino Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "El Camino Hospital" are "Breast Cancer" (11 trials), "Lung Cancer" (6 trials), "Recurrent Breast Carcinoma" (6 trials), "Colorectal Cancer" (5 trials) and "Stage IIIC Breast Cancer AJCC v7" (5 trials). Many other conditions were trialed in "El Camino Hospital" in a lesser frequency.

Most popular intervention types in "El Camino Hospital" are "Drug" (71 trials), "Other" (44 trials), "Device" (39 trials), "Biological" (29 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Bevacizumab" (15 trials), "Paclitaxel" (14 trials), "Carboplatin" (12 trials) and "Quality-of-Life Assessment" (11 trials). Other intervention names were less common.

The vast majority of trials in "El Camino Hospital" are 94 trials for "All" genders, 23 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "El Camino Hospital". undefined are not yet recruiting, 6 are recruiting, 36 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in El Camino Hospital, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in El Camino Hospital, 5 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 30 trials that are defined as “Not Applicable".